Review: taking Relpax and Zoloft together


Summary

Drug interactions are reported among people who take Relpax and Zoloft together. This review analyzes the effectiveness and drug interactions between Relpax and Zoloft. It is created by eHealthMe based on reports of 142 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Relpax and Zoloft >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Relpax

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. (latest outcomes from Relpax 3,820 users)

Zoloft

Zoloft has active ingredients of sertraline hydrochloride. It is often used in depression. (latest outcomes from Zoloft 86,060 users)

On Aug, 27, 2016

142 people who take Relpax, Zoloft are studied.


Number of reports submitted per year:

Relpax and Zoloft drug interactions.

Drug effectiveness over time:

Relpax:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 100.0% - (2 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (2 of 2 people)
  • 10+ years: 100.0% - (2 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Zoloft:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 66.0% - (2 of 3 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Relpax:
  • female: 71.0% - (5 of 7 people)
  • male: 100.0% - (1 of 1 people)
Zoloft:
  • female: 50.0% - (4 of 8 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Relpax:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 50.0% - (2 of 4 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 0.0% - (0 of 0 people)
Zoloft:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 40.0% - (2 of 5 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • nausea
  • pain in extremity
  • back pain
  • chest pain
  • abdominal pain
  • arthralgia
  • decreased activity
  • drug ineffective
  • headache
  • migraine
5 - 10 years:
  • back pain
  • bone and joint pain
not specified:
  • pain
  • depression
  • dyspnoea
  • migraine
  • dizziness
  • headache
  • deep vein thrombosis
  • agitation
  • injury
  • nausea

Most common drug interactions by gender *:

female:
  • depression
  • pain
  • dyspnoea
  • migraine
  • deep vein thrombosis
  • headache
  • dizziness
  • drug ineffective
  • nausea
  • agitation
male:
  • chest pain
  • injury
  • abdominal pain
  • back pain
  • decreased activity
  • dizziness
  • emotional distress
  • fatigue
  • headache
  • migraine

Most common drug interactions by age *:

10-19:
  • cerebral vasoconstriction
20-29:
  • deep vein thrombosis
  • depression
  • convulsion
  • dizziness
  • eye rolling
  • grand mal convulsion
  • muscle spasms
  • photopsia
  • pulmonary embolism
  • back pain
30-39:
  • dyspnoea
  • pain in extremity
  • palpitations
  • chest pain
  • dizziness
  • migraine
  • pain
  • pulmonary embolism
  • pleural effusion
  • abdominal pain
40-49:
  • deep vein thrombosis
  • drug ineffective
  • nausea
  • pain
  • back pain
  • drug effect decreased
  • migraine
  • abdominal pain
  • anxiety
  • arthralgia
50-59:
  • headache
  • spinal osteoarthritis
  • drug ineffective
  • cough
  • dyspnoea
  • fatigue
  • insomnia
  • adenoma benign
  • breast cancer
  • breast cancer in situ
60+:
  • agitation
  • tobacco withdrawal symptoms
  • fall
  • chest discomfort
  • depressed mood
  • muscle spasms
  • pain
  • pain in extremity
  • back pain
  • blood creatinine increased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Relpax and Zoloft?

Can you answer these questions?

More questions for: Relpax, Zoloft

You may be interested in these reviews

More reviews for: Relpax, Zoloft

On eHealthMe, Relpax (eletriptan hydrobromide) is often used to treat migraine. Zoloft (sertraline hydrochloride) is often used to treat depression. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.